跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
QUIXIL
Authorized
STANDARD
QUIXIL
OMRIX BIOPHARMACEUTICALS LTD
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
7d1e79007942fbb9
Company
OMRIX BIOPHARMACEUTICALS LTD
Type
Standard
Approval Details
Approval Id
7d1e79007942fbb9
Drug Approval Canada Name
QUIXIL
Product Name
QUIXIL
Status
Approved
Status Date
2006-07-24
Din
02283980
Drug Class
Human
Dosage Form
Kit , Solution
Route Of Administration
Topical
Schedule
Schedule D
Ahfs
20:28.16
Atc Original
B02BC30 COMBINATIONS
Atc Name
b 02 bc 30
Aig Number
0351655001
Company Name
OMRIX BIOPHARMACEUTICALS LTD
Company Address
Mda Blood Bank, Sheba Hospital, Ramat-Gan, Kiryat Ono, Tel-Aviv, Israel, 5510801
Company Detail Path
/organization/omrix-biopharmaceuticals-ltd
Company Information
Pharmaceutical Company Name
OMRIX BIOPHARMACEUTICALS LTD
Country Name
Israel
Province Name
Central District
City Name
ramat gan,central district,country_il
Address
MDA Blood Serv.Sheba Hospital
Active Ingredients
FIBRINOGEN (HUMAN)
60.0 MG / ML
THROMBIN (HUMAN)
1200 UNIT / ML
CALCIUM CHLORIDE
6.2 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
7d1e79007942fbb9
Type
Standard
Back to Health Canada Approvals